These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8488758)

  • 21. Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease.
    Blennow K; Hesse C; Fredman P
    Neuroreport; 1994 Dec; 5(18):2534-6. PubMed ID: 7696597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of molecular interactions between ApoE, amyloid-beta (Aβ) and laminin: Relevance to accumulation of Aβ in Alzheimer's disease.
    Zekonyte J; Sakai K; Nicoll JA; Weller RO; Carare RO
    Biochim Biophys Acta; 2016 May; 1862(5):1047-53. PubMed ID: 26327683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased cerebrospinal fluid levels of neurosin (KLK6), an aging-related protease, as a possible new risk factor for Alzheimer's disease.
    Mitsui S; Okui A; Uemura H; Mizuno T; Yamada T; Yamamura Y; Yamaguchi N
    Ann N Y Acad Sci; 2002 Nov; 977():216-23. PubMed ID: 12480753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer's disease: Elevated pigment epithelium-derived factor in the cerebrospinal fluid is mostly of systemic origin.
    Lang V; Zille M; Infante-Duarte C; Jarius S; Jahn H; Paul F; Ruprecht K; Pina AL
    J Neurol Sci; 2017 Apr; 375():123-128. PubMed ID: 28320113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic utility of serum or cerebrospinal fluid levels of toxic advanced glycation end-products (TAGE) in early detection of Alzheimer's disease.
    Takeuchi M; Sato T; Takino J; Kobayashi Y; Furuno S; Kikuchi S; Yamagishi S
    Med Hypotheses; 2007; 69(6):1358-66. PubMed ID: 17888585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined analysis of CSF betaA42 peptide and tau protein and serum antibodies to glycosaminoglycans in Alzheimer's disease: preliminary data.
    Briani C; Ruggero S; Naccarato M; Cagnin A; Ricchieri GL; Pasqui L; Pizzolato G; Battistin L
    J Neural Transm (Vienna); 2002 Mar; 109(3):393-8. PubMed ID: 11956959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity.
    Hock C; Golombowski S; Müller-Spahn F; Naser W; Beyreuther K; Mönning U; Schenk D; Vigo-Pelfrey C; Bush AM; Moir R; Tanzi RE; Growdon JH; Nitsch RM
    Eur Neurol; 1998; 39(2):111-8. PubMed ID: 9520072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased cerebrospinal fluid levels of double-stranded RNA-dependant protein kinase in Alzheimer's disease.
    Mouton-Liger F; Paquet C; Dumurgier J; Lapalus P; Gray F; Laplanche JL; Hugon J;
    Biol Psychiatry; 2012 May; 71(9):829-35. PubMed ID: 22281122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid acetylcholinesterase activity in senile dementia of the Alzheimer type.
    Tune L; Gucker S; Folstein M; Oshida L; Coyle JT
    Ann Neurol; 1985 Jan; 17(1):46-8. PubMed ID: 3985585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amino acid concentrations in cerebrospinal fluid and serum in Alzheimer's disease and vascular dementia.
    Martinez M; Frank A; Diez-Tejedor E; Hernanz A
    J Neural Transm Park Dis Dement Sect; 1993; 6(1):1-9. PubMed ID: 8216758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased acidic fibroblast growth factor concentrations in the serum and cerebrospinal fluid of patients with Alzheimer's disease.
    Mashayekhi F; Hadavi M; Vaziri HR; Naji M
    J Clin Neurosci; 2010 Mar; 17(3):357-9. PubMed ID: 20079650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
    Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
    Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Albumin Oxidation in Cerebrospinal Fluid and Plasma from Alzheimer's Disease Patients.
    Costa M; Horrillo R; Ortiz AM; Pérez A; Mestre A; Ruiz A; Boada M; Grancha S
    J Alzheimers Dis; 2018; 63(4):1395-1404. PubMed ID: 29782326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tau protein and apolipoprotein E in CSF diagnostics of Alzheimer's disease: impact on non Alzheimer's dementia?
    Rösler N; Wichart I; Bancher C; Jellinger KA
    J Neural Transm Suppl; 1996; 47():259-66. PubMed ID: 8841971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease.
    Vickers JC; Riederer BM; Marugg RA; Buée-Scherrer V; Buée L; Delacourte A; Morrison JH
    Neuroscience; 1994 Sep; 62(1):1-13. PubMed ID: 7816192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease.
    de la Monte SM; Volicer L; Hauser SL; Wands JR
    Ann Neurol; 1992 Dec; 32(6):733-42. PubMed ID: 1471863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid chromogranin A is unchanged in Alzheimer dementia.
    O'Connor DT; Kailasam MT; Thal LJ
    Neurobiol Aging; 1993; 14(3):267-9. PubMed ID: 8321395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased plasma and cerebrospinal fluid levels of stem cell factor in patients with early Alzheimer's disease.
    Laske C; Stellos K; Stransky E; Seizer P; Akcay O; Eschweiler GW; Leyhe T; Gawaz M
    J Alzheimers Dis; 2008 Nov; 15(3):451-60. PubMed ID: 18997298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease.
    Su JH; Cummings BJ; Cotman CW
    Neuroscience; 1992 Dec; 51(4):801-13. PubMed ID: 1488123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.